The abstract is read at the publisher; the summary is JClub's.
Degenerative mitral valve regurgitation from mitral valve prolapse affects about 15 million people globally and remains poorly defined in biology, natural history, and lifetime management.
- Why it matters: The field lacks clear mechanistic understanding and risk-guided, lifelong strategies, limiting detection and prevention of downstream myocardial dysfunction, especially in high-risk phenotypes like arrhythmic mitral prolapse.
- What they did: This review consolidates evidence on epidemiology, pathophysiology, diagnosis, risk stratification, and management, highlighting translational work on genetic and cellular drivers and mechanistic studies for earlier detection.
- The result: It maps emerging research and the current trial/registry landscape comparing contemporary surgical versus transcatheter approaches and access-to-care strategies across risk profiles and populations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.